Please complete the CAPTCHA to continue
@onltherapeutics.com
✓
5 phones found area 269, 781, and 844
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
David Esposito is listed as Chief Executive Officer at ONL Therapeutics at ONL Therapeutics, based in Ann Arbor, Michigan, United States. AeroLeads shows a work email signal at onltherapeutics.com, phone signal with area code 269, 781, 844, and a matched LinkedIn profile for David Esposito.
David Esposito previously worked as President and Chief Executive Officer at Onl Therapeutics and Member of the Board of Directors at Allergenis. David Esposito holds Bachelor Of Science (Bs), Civil Engineering from United States Military Academy At West Point.
This section adds company-level context without repeating David Esposito's masked contact details.
AeroLeads found 1 current-domain work email signal for David Esposito. Compare company email patterns before reaching out.
David is an experienced healthcare CEO and combat veteran.He has built and scaled multiple healthcare companies that resulted in successful exits.- CEO: Armune BioScience (sold to Exact Sciences [EXAS] Dec. 2017).- US President: Phadia US/AB (sold to Thermo Fisher Scientific [TMO] Sept. 2011)
Listed skills include Pharmaceutical Industry, Product Launch, Strategy, Cross Functional Team Leadership, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Ann Arbor, Michigan, US
ONL Therapeutics is a biopharmaceutical company committed to protecting the vision of patients with a range of retinal diseases and conditions. ONL is the first and only company focused on preventing Fas-mediated death of key retinal cells, which is a root cause of vision loss and a leading cause of blindness.
Hatfield, Pennsylvania, US
AllerGenis is revolutionizing the diagnosis and management of food allergies with blood testing based on epitope-mapping technology.AllerGenis was formed from a collaboration between Genisphere (proprietary amplification technology to increase the sensitivity of diagnostic tests) and Hugh Sampson, M.D., Director of the Jaffe Food Allergy Institute of the.
Frisco, Texas, US
Hemotek is focused on bringing the benefits of Ox66 to multiple segments in the life science market. Ox66 is the only solid form of oxygen, designed to be taken orally or applied topically, for its healing and pain relieving properties. Ox66 has the proven potential to provide oxygen to for any insult or injury to the human body resulting in low oxygen.
Ann Arbor, Michigan, US
Harvest Time Partners, Inc. is a personal and professional development company.We help YOU be your BEST for those you care about most - At Home - At Work - In Your CommunityWe create products and services to help YOU in the journey to reach your full potential.
Shield Bio has developed the Target-X platform, a solution to microbial detection, species identification and antibiotic susceptibility prediction with blazing speed and accuracy.Shield Bio is building universal sequencing and has made 3rd Gen Sequencing work reliably and accurately in less than 1 minute
EMA Partners supports middle market companies in evaluating and executing on key strategic initiatives including: (1) Business strategy transformation (2) Company sales, divestitures, and buy side acquisitions (3) Licensing and intellectual property monetization and (4) Capital raises and recapitalizations
Armune BioScience developed and commercialized unique technology leveraging the immune system’s response to several types of cancers. Armune gained the interest of numerous strategic buyers and closed a deal with Exact Sciences in December of 2017 to acquire core assets of the business.
Arlington, Virginia, US
Infantry Company Executive Officer: Responsible for leading over 125 infantry soldiers on several successful US training deployments.Infantry Platoon Leader: 1st Platoon, A Company, 1/327 INF. Led a 38 man rifle platoon into combat operations during Operation Desert Shield/Desert Storm.
Quick answers generated from the profile data available on this page.
David Esposito works for ONL Therapeutics.
David Esposito is listed as Chief Executive Officer at ONL Therapeutics at ONL Therapeutics.
AeroLeads has found 1 work email signal at @onltherapeutics.com for David Esposito at ONL Therapeutics.
AeroLeads has found 5 phone signal(s) with area code 269, 781, 844 for David Esposito at ONL Therapeutics.
David Esposito is based in Ann Arbor, Michigan, United States while working with ONL Therapeutics.
David Esposito has worked for Onl Therapeutics, Allergenis, Hemotek, Harvest Time Partners, Inc., and Shield Bio.
You can use AeroLeads to view verified contact signals for David Esposito at ONL Therapeutics, including work email, phone, and LinkedIn data when available.
David Esposito holds Bachelor Of Science (Bs), Civil Engineering from United States Military Academy At West Point.
David Esposito is listed with skills including Pharmaceutical Industry, Product Launch, Strategy, Cross Functional Team Leadership, Leadership, Pharmaceutical Sales, Commercialization, and Management.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts